C1704256||Transforming Growth Factor Beta 1
C1704256||Transforming Growth Factor Beta 1
C0007115||Thyroid Cancer
C0229664||Peripheral Blood
C0040690||Transforming growth factor beta
C0040690||Transforming growth factor beta
C0006826||cancer
C0040690||Transforming growth factor beta
C1337013||differentiated thyroid cancer
C1337013||differentiated thyroid cancer
C0332128||examined
C2603343||study
C0040690||Transforming growth factor beta
C1550100||serum samples
C0031858||PHA
C0038337||stimulated
C0370231||whole blood
C0200949||culture
C0936012||analyze
C1704256||Transforming Growth Factor Beta 1
C0023516||leukocyte
C0024264||lymphocyte
C0005821||platelets
C0007584||counts
C0007115||thyroid cancer
C1704256||Transforming Growth Factor Beta 1
C1337013||differentiated thyroid cancer
C0812225||duoSet ELISA Development kit
C0080222||human TGF-Î²1
C1704256||Transforming Growth Factor Beta 1
C1550100||serum samples
C1257890||groups
C0005821||platelet
C0007584||counts
C1704256||Transforming Growth Factor Beta 1
C1337013||differentiated thyroid cancer
C0031858||PHA
C0038337||stimulated
C0370231||whole blood
C0200949||cultures
C1337013||differentiated thyroid cancer
C1704256||Transforming Growth Factor Beta 1
C2603343||studies
C0243095||findings